Skip to content

Phreesia PHR Treasury Stock

Treasury Stock at other companies

Claritev Corporation logo
Claritev CorporationCTEV
$138.73M0.0%
Corvel logo
CorvelCRVL
$887.72M+6.8%
ExlService Holdings logo
ExlService HoldingsEXLS
$1.26B+56.6%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$61.43M+191%
Paysign logo
PaysignPAYS
$2.35M+9.3%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$835.74M+37.3%

Other financials

Income statement

See full
Revenue$130.9M+12.9%
Gross profit$113.3M+14.1%
Operating income$6.7M+305%
Net income$3.0M+176%
EPS (diluted)$0.05+171%

Balance sheet

See full
Cash & equivalents$73.8M-12.3%
Total debt$98.3M+242%
Total equity$359.1M+27.3%
Total assets$666.1M+66.4%

Cash flow

See full
Operating cash flow$23.9M+61.1%
CapEx$4.3M+23.0%
Free cash flow$19.6M+72.9%

Valuation

See full
Market cap$564.34M-63.8%
P/E61.5×
P/S1.1×-2.5×

Profitability

See full
Gross margin85.4%+0.8pp
Operating margin0.7%+0.4pp
Net margin1.9%+1.0pp
FCF margin15.3%+6.9pp

Returns & leverage

See full
Return on equity2.9%+1.5pp
Debt / equity0.3×+0.2×
Current ratio1.8×-0.2×

Where this comes from

Reported directly by Phreesia in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: Phreesia’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phreesia's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phreesia's treasury stock?
Phreesia (PHR) reported treasury stock of $46.62M in Q1 2026.
How has Phreesia's treasury stock changed year-over-year?
Phreesia's treasury stock increased by 2.4% year-over-year, from $45.52M to $46.62M.
What is the long-term trend for Phreesia's treasury stock?
Over 5 years (2021 to 2026), Phreesia's treasury stock has grown at a 55.8% compound annual growth rate (CAGR), from $4.97M to $45.52M.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.